Induction treatment before surgery for non-small cell lung cancer

被引：56

作者：

Eberhardt, WE

Albain, KS

Pass, H

Putnam, JB

Gregor, A

Assamura, H

Mornex, F

Senan, S

Belderbos, J

Westeel, V

Thomas, M

Van Schil, P

Vansteenkiste, J

Manegold, C

Mirimanoff, RO

Stuschke, M

Pignon, J

Rocmans, P

Shepherds, FA

机构：

[1] Duisburg Essen Univ, Sch Med, W German Canc Ctr, Dept Internal Med, D-45122 Essen, Germany

[2] Loyola Univ, Ctr Med, Cardinal Bernardin Canc Ctr, Maywood, IL USA

[3] Wayne State Univ, Detroit, MI USA

[4] Harper Univ Hosp, Karmanos Canc Inst, Detroit, MI USA

[5] MD Anderson Canc Ctr, Houston, TX USA

[6] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland

[7] Natl Canc Ctr Hosp, Tsukiji, Japan

[8] Ctr Hosp Lyon, Radiat Oncol Dept, Lyon, France

[9] VU Univ Med Ctr, Amsterdam, Netherlands

[10] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands

[11] J Minjoz Univ Hosp, Chest Dis Dept, Besancon, France

[12] Univ Munster, Dept Hematol Oncol & Resp Med, Munster, Germany

[13] Dept Thorac & Vasc Surg, Antwerp, Belgium

[14] Univ Hosp, Resp Oncol Unit Pulm, Louvain, Belgium

[15] Thoraxklin Heidelberg, Heidelberg, Germany

[16] Univ Lausanne, Dept Radiat Oncol, Lausanne, Switzerland

[17] Duisburg Essen Univ, Sch Med, Dept Radiat Oncol, Essen, Germany

[18] Inst Gustave Roussy, Villejuif, France

[19] Hosp Erasme Univ Libre Bruxelles, Brussels, Belgium

[20] Princess Margaret Hosp, Toronto, ON, Canada

来源：

LUNG CANCER | 2003年 / 42卷

关键词：

induction therapy; chemotherapy; radiotherapy; chemoradiation; surgery;

D O I：

10.1016/S0169-5002(03)00300-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Surgery alone is currently still accepted "standard of care" for patients with operable NSCLC, this includes stages IA and IIB, as well as selected early subsets of IIIA disease. In more advanced and inoperable stage III disease, combinations of chemotherapy and radiotherapy remain the standard treatment approach for patients with good performance status. The role of surgery following induction therapy in these advanced stage III patients is at the moment not conclusively defined. More evidence from randomized trials is clearly needed to tailor treatment for the large

引用

页码：S9 / S14

页数：6

共 23 条

[1]

ALBAIN K, 1999, P AN M AM SOC CLIN, V18, pA1801

[2] Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications [J].

Andre, F ;

Grunenwald, D ;

Pignon, JP ;

Dujon, A ;

Pujol, JL ;

Brichon, PY ;

Brouchet, L ;

Quoix, E ;

Westeel, V ;

Le Chevalier, T .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2981-2989

[3]

BURKER RL, 2000, P AN M AM SOC CLIN, V19, pA1941

[4] Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer [J].

Choi, NC ;

Carey, RW ;

Daly, W ;

Mathisen, D ;

Wain, J ;

Wright, C ;

Lynch, T ;

Grossbard, M ;

Grillo, H .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :712-722

[5] Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial [J].

de Boer, RH ;

Smith, IE ;

Pastorino, U ;

O'Brien, MER ;

Ramage, F ;

Ashley, S ;

Goldstraw, P .

BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1514-1518

[6] Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].

Depierre, A ;

Milleron, B ;

Moro-Sibilot, D ;

Chevret, S ;

Quoix, E ;

Lebeau, B ;

Braun, D ;

Breton, JL ;

Lemarié, E ;

Gouva, S ;

Paillot, N ;

Bréchot, JM ;

Janicot, H ;

Lebas, FX ;

Terrioux, P ;

Clavier, J ;

Foucher, P ;

Monchâtre, M ;

Coëtmeur, D ;

Level, MC ;

Leclerc, P ;

Blanchon, F ;

Rodier, JM ;

Thiberville, L ;

Villeneuve, A ;

Westeel, V ;

Chastang, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253

[7] Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer:: Mature results of a phase II trial [J].

Eberhardt, W ;

Wilke, H ;

Stamatis, G ;

Stuschke, M ;

Harstrick, A ;

Menker, H ;

Krause, B ;

Müeller, MR ;

Stahl, M ;

Flasshove, M ;

Budach, V ;

Greschuchna, D ;

Konietzko, N ;

Sack, H ;

Seeber, S .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :622-634

[8] INDUCTION THERAPY FOR STAGE-III NSCLC - A CONSENSUS REPORT [J].

GREEN, MR ;

GINSBERG, R ;

ARDIZZONI, A ;

CHOI, N ;

DARWISH, S ;

FUKUOKA, M ;

GINER, V ;

GRUNENWALD, D ;

HARPER, P ;

KHO, S ;

LECHEVALIER, T ;

LEWINSKI, T ;

PAYNE, D ;

POSTMUS, P ;

ROCMANS, P ;

ROSELL, R ;

ROTH, J ;

SCULIER, JP ;

SORENSEN, JB .

LUNG CANCER, 1994, 11 :S9-S10

[9] Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer [J].

Grunenwald, DH ;

André, F ;

Le Péchoux, C ;

Girard, P ;

Lamer, C ;

Laplanche, A ;

Tarayre, M ;

Arriagada, R ;

Le Chevalier, T .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (04) :796-802

[10] Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); Final report of RTOG 89-01 [J].

Johnstone, DW ;

Byhardt, RW ;

Ettinger, D ;

Scott, CB .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :365-369

← 1 2 3 →